Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab  by Addonizio, Linda J. et al.
lACC Vol. 9. No.3
March 1987:555-64
Imaging of Cardiac Allograft Rejection in Dogs Using Indium-Ill
Monoclonal Antimyosin Fab
LINDA J. ADDONIZIO, MD, ROBERT E. MICHLER, MD, CHARLES MARBOE, MD,
PETER E. ESSER, PHD, LYNNE L. JOHNSON, MD, FACC, DAVID W. SELDIN, MD,
WELTON M. GERSONY, MD, FACC, PHILIP O. ALDERSON, MD, ERIC A. ROSE, MD,
PAULJ.CANNON,MD,FACC
New York. New York
555
The acute rejection of cardiac allografts is currently di-
agnosed by the presence of myocyte necrosis on endo-
myocardial biopsy. We evaluated the efficacy of nonin-
vasive scintigraphic imaging with indium-Ill-labeled
anticardiac myosin Fab fragments (indium-Ill anti-
myosin)to detect and quantify cardiac allograft rejection.
Six dogs that had intrathoracic heterotopic cardiac allo-
graft transplantation were injected with indium-Ill anti-
myosin and planar and single photon emission computed
tomographic (SPECT) images were obtained in var-
iousstages ofacute and subacute rejection. Four dogs had
an allograft older than 8 months and had been on long-
term immunosuppressive therapy; two dogs had an allo-
graft less than 2 weeks old and were not on immunosup-
pressive therapy. Count ratios comparing heterotopic
with native hearts were calculated from both SPECT
images and in vitro scans of excised and sectioned
hearts and were compared with the degree of rejec-
Cardiac transplantation is becoming an increasingly ac-
cepted form of therapy for end stage cardiac disease. Im-
proved success with this treatment has been attributed to
the use of cyclosporine immunosuppression (1). The Inter-
national Heart Transplantation Registry recently reported an
80% I year survival rate after cardiac transplantation using
cyclosporine immunosuppression compared with 60% using
conventional azathioprine and prednisone therapy (2). The
use of cyclosporine, however, makes the diagnosis of car-
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tion scored by an independent histopathologic review.
Indium-Ill antimyosinuptake wasnot visible in planar
or SPECT images of native hearts. Faint diffuse uptake
was apparent in cardiac allografts during long-term im-
munosuppression and intense radioactivity was present
in hearts with electrocardiographic evidenceof rejection.
The heterotopic to native heart count ratios in SPECT
images correlated significantly with the count ratios in
the excisedhearts (r =0.93) and with the histopathologic
rejection score (r = 0.97). The distribution of indium-
111 antimyosin activity in right and left ventricles cor-
responded to areas of histopathologic abnormalities. Im-
munoperoxidase studies showed deposition of indium-
111 antimyosin only in areas of myocyte necrosis. The
results demonstrate that indium-Ill antimyosin imaging
can noninvasively detect the presence, location and se-
verity of canine cardiac allograft rejection.
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diac allograft rejection more difficult. The current definitive
method for the diagnosis of cardiac allograft rejection in
patients receiving cyclosporine immunosuppression is the
endomyocardial biopsy and the pathologic hallmark of sig-
nificant rejection is myocyte necrosis (1,3). Cardiac biopsy,
however, is invasive and inconvenient. Currently available
noninvasive methods are either nonspecific indicators of
myocardial dysfunction or have not proved clinically useful
in specifically diagnosing allograft rejection (3-5).
Khaw, Frame and colleagues (6-9) developed the method
for detecting and localizing a myocardial infarct employing
intravenously administered radiolabeled fragments of anti-
bodies specific for cardiac myosin. In an extensive series
of experiments, they found that labeled polyclonal anticar-
diac myosin antibodies, F(ab'h and Fab fragments of these
antibodies localize in myocardial cells irreversibly damaged
by an ischemic insult. More recently (10) they used hy-
bridoma technology to produce monoclonal antibodies to
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human cardiac myosin. Conjugation of Fab fragments of
these monoclonal antibodies to the bifunctional chelating
agent, diethyelenetriamine pentaacetic acid, facilitated ra-
diolabeling with either technetium-99m or indium-III. Thus,
a monoclonal antibody Fab fragment specific for human
cardiac myosin labeled with a radionuclide was produced
for imaging of myocardial infarction in vivo by gamma
scintigraphy (10).
The purpose of our study in experimental animals was
to test whether the scattered myocyte necrosis that occurs
on a microscopic level during cardiac allograft rejection can
be detected and localized scintigraphically using indium-
III-labeled monoclonal antimyosin Fab fragments (in-
dium-III antimyosin). A secondary objective was to de-
termine whether the degree of Fab uptake visualized on the
scintigrams was related to the severity of allograft rejection
determined by histopathologic examination. Successful ap-
plication of such scintigraphic approaches may ultimately
lead to a noninvasive test for cardiac transplant rejection
that could be an effective alternative to endomyocardial
biopsy.
Methods
Animal model. Six adult mongrel dogs that had under-
gone intrathoracic heterotopic cardiac allograft transplan-
tation were studied. This experimental model was chosen
so that the native heart of each dog could serve as a control
for the transplanted heart. Cardiac transplantation was per-
formed according to the method described by Jamieson et
al. (II). Outbred mongrel donor dogs weighing 9 to 14 kg
were matched with recipient dogs weighing 14 to 23 kg.
Donor and recipient pairs were anesthetized with sodium
pentobarbital and were ventilated with a Harvard respirator.
The donor heart was arrested with cold crystalloid cardi-
oplegia solution and harvested through a median sternot-
omy. A left thoracotomy was performed on the recipient
and after creation of an atrial septal defect and mitral in-
competence in the donor heart, the donor aorta and pul-
monary artery were anastomosed end to side to the recipient
left innominate artery and superior vena cava, respectively.
Antibody preparation. Monoclonal anti-human cardiac
myosin antibodies that also cross-react with canine cardiac
myosin were prepared from murine sera and were purified
by Centocor, Inc. These antibodies were originally devel-
oped by Khaw et al. (10). Using the technique of somatic
cell fusion, spleen cells from Balb/c mice immunized with
human cardiac myosin were fused with a plasmacytoma cell
line to make the hybrid cell line RIIDIO. Fab fragments
of the IgG antibody produced by these cells were prepared
by mercuripapain digestion and then covalently attached to
DTPA. The resultant Fab-DTPA molecules were suspended
in 0.1 M sodium citrate buffer in preparation for imaging.
Imaging protocol. The preparation of the indium-III-
labeled Fab for imaging involved incubation of 2 to 3 mCi
of indium-III chloride with the citrate-buffered antimyosin
Fab-DTPA at room temperature. The percent of isotope
binding to protein was determined using paper chromatog-
raphy. All injectates used in this study had more than 95%
of the indium-Ill bound to the protein. The dissociation of
the indium from the antimyosin occurs at less than 1% per
day until the antibody is cleared.
Imaging was performed 24 hours after the intravenous
injection of 2 to 3 mCi of indium-Ill antimyosin. The 24
hour time interval was chosen based on blood clearance
curves that showed a slow disappearance of indium-III
antimyosin with the curve reaching a low steady state by
24 to 48 hours. A dual-headed tomographic imaging system
(Picker International) with matched sodium iodide detectors
and medium energy parallel hole collimators was used to
obtain single photon emission tomographic images (SPECT).
Pulse-height analyzer windows were set to record both the
169 and 240 keV photopeaks of indium-III with a 15%
window width. The dogs were anesthetized with 30 mg/kg
body weight intravenous sodium pentobarbital. They were
intubated but allowed to breathe spontaneously and were
placed in the right lateral decubitus position on the pallet
of the SPECT camera. Data were acquired by each camera
head for I minute at each of 30 projections as the gantry
rotated in a 1800 circular arc, yielding a 3600 acquisition
with 60 total projection images. Typical images contained
150,000 to 250,000 counts. Total scanning time was 30
minutes.
Through a direct digital interface, a dedicated mini-
computer (A3, Medical Data Systems) stored the data in a
64 x 64 word matrix using 1.33 x software magnification
for later computer reconstruction. Subsequent 5 minute static
acquisitions in the anterior and left lateral positions also
were obtained. These images contained approximately
500,000 to 750,000 counts.
Thallium-201 imaging was performed immediately after
indium-III imaging to help delineate both cardiac borders
in each dog. Thallium-201 chloride (2 mCi) was injected
and planar and SPECT images were acquired after a 10
minute equilibration period using the same protocol de-
scribed for indium-Ill imaging. The 70 keY photopeak of
thallium-201 and a 15% window were used for acquisition
of these scans. Total counts in thallium-201 images were
approximately 75% of the total counts in corresponding
indium-Ill views.
Immunosuppression protocols. To test the effective-
ness of indium-Ill antimyosin in detecting and quanti-
tating rejection over a range of histopathologic rejection
grades, the dogs were studied according to several protocols
(Table 1).
As a model of severe early rejection, two animals (Dogs
JACC Vol. 9. No.3
March 1987:555-64
ADDONIZIO ET AL.
IMAGING OF CARDIAC ALLOGRAFT REJECTION
557
Table 1. Heterotopic Cardiac Allograft Imaging Sequence
Time From
Transplant Baseline Rejection
to Scan Immunosuppression Scan Scan
Acute
Dog I 10 Days No Yes
Dog 2 4 Days No Yes
Chronic
Dog 3 8 Mo Yes Yes No
Dog 4 9 Mo Yes Yes Yes
Dog 5 8 Mo Yes Yes Yes
Dog 6 10 Mo Yes Yes Yes
Immunosuppression
for Second Scan
No
No
Yes
Time Between
Scans
16 Days
27 Days
14 Days
I and 2) underwent cardiac transplantation and the hearts
were allowed to reject without immunosuppression. Thal-
lium-20! and indium-III antimyosin scans were obtained
on one donor and recipient dog pair before surgery to look
for possible indium-III antimyosin uptake in normal hearts
and to provide a baseline for comparison with later scans.
After transplantation, daily electrocardiograms were per-
formed until allograft rejection was suspected, as evidenced
by a 25% decrement in the R wave voltage ratio of the
transplanted and the native heart, QRS wave widening or
significant arrhythmia. When electrocardiographic evidence
of rejection occurred, indium-III antimyosin and thallium-
20 I scans were performed as described under Imaging Pro-
tocol and the dogs were killed for pathologic examination.
The four remaining dogs (Dogs 3 to 6) represented long-
term transplantation survivors on chronic immunosuppres-
sive therapy. This model was selected to evaluate whether
operative trauma affected the antimyosin antibody imaging.
Dogs in this group had undergone heterotopic transplanta-
tion more than 8 months before study and had been main-
tained on prednisone (5 mg/day) and azathioprine (2 mg/kg
per day) immunosuppression since surgery. Azathioprine
immunosuppression was chosen for our long-term dog models
because it is possible to clinically detect early rejection with
this regimen using electrocardiographic changes as criteria.
In this way we could more accurately determine when to
perform the second scans.
Dog 3 was given an injection, scanned and killed while
receiving this long-term immunosuppressive therapy and
without electrocardiographic evidence of rejection to serve
as a control for the other long-term dogs. DORS 4 and 5
were each studied twice to characterize the changes in scans
that occur with the development of rejection. In these dogs,
baseline scans were performed while they were receiving
immunosuppressive therapy; after that the medications were
discontinued and the dogs were allowed to develop allograft
rejection. When electrocardiographic changes suggestive of
rejection were present, the dogs were given another injec-
tion, indium-III antimyosin, rescanned and killed. DOR 6,
also on long-term immunosuppression, spontaneously began
to reject according to electrocardiographic criteria on the
day of the initial scan. Because this dog was clinically well,
this episode of rejection would not have been detected had
the dog not been entered into the protocol. This animal,
therefore, represented a model of undetected rejection in
the presence of immunosuppressive therapy. After the base-
line scan was performed, Dog 6 was maintained on treatment
at the same doses for 2 weeks and was then restudied and
killed.
Data analysis. All single photon emission computed
tomographic (SPECT) images were reconstructed using a
filtered back projection algorithm with a Butterworth filter
(cutoff: 0.15, order: 25) to reduce background noise arti-
facts. Reconstructed transaxial slices were 9.86 mm (2 pix-
els) thick and were aligned along the long axis of the dog
in a caudad-cephalad orientation. Eight to 10 transaxial slices
of each heart usually contained all the visualized indium-
III antimyosin activity. Indium-III activity also was pres-
ent in the liver, spleen and kidneys. To compare the relative
activity of indium-Ill antimyosin in the heterotopic and
native hearts, the borders of the two hearts were first lo-
calized on the thallium-20! scans and regions of interest
were drawn manually on the corresponding indium-III scans
for each heart from the transaxial slice that visually con-
tained the highest counts. Background regions were also
drawn. A ratio of the average counts per pixel (corrected
for background) in the heterotopic compared with the native
heart of each dog (heterotopic to native heart count ratio)
was calculated.
Individual segments of each heart were dissected post-
mortem, as described under Pathologic Examination, and
these segments were scanned by placing them on the face
of one of the scintillation heads of the SPECT imaging
system. Two static images were acquired for 15 minutes
each using first the 240 keY photopeak of indium-III and
then the 70 keY photo peak of thallium-20!. Regions of
interest were drawn manually around the images of the tissue
segments of both the native and the heterotopic hearts and
heterotopic to native heart count ratios were calculated for
comparison with the ratios obtained in vivo.
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cific). Antibody localization was finally demonstrated by
incubation with a solution of 3,3-diaminobenzidine tetra-
hydrochloride (Sigma) at a concentration of 0.9 mg/ml in
0.03% hydrogen peroxide in modified phosphate-buffered
saline solution (13), pH 7.4. Sections were counterstained
with Light Green (Fisher Scientific), dehydrated, perma-
nently mounted and examined with light microscopy.
Figure 1. Dog I. A, Baseline left lateral planar images of the
donor dog for Dog I (thallium on the left, indium on the right).
B, The cardiac region outlined was identified using the thallium
image and shows the position of the heart on the indium scan. No
significant indium activity is present in the heart before transplan-
tation. C, The left lateral planar indium image of Dog I, which
received the heart shown in panel A, left. There is now intense
uptake of indium in the region of the heterotopic heart superiorly
that corresponded to histopathologic findings of acute severe re-
jection (compare with A, right). There is no activity in the native
heart inferiorly.
c
A
B
li uer
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Results
Acute Allograft Rejection
The planar and SPECr scans performed on the donor
and recipient dogs with a normal heart before transplantation
showed no significant uptake of indium-III monoclonal
antimyosin Fab (Fig. I). Also, no uptake was visible in
planar or SPECT images of the recipient's native heart after
transplantation. In contrast, intense radioactivity was pres-
ent in the scintigraphic images of the transplanted hearts
of both Dog I (10 days after transplantation) and Dog 2
(4 days after transplantation) when there was electrocardio-
Pathologic examination. Both hearts were removed and
rinsed in normal saline solution before dissection. The atria
and great vessels were discarded and each heart was divided
into three sections, the right ventricular free wall, the in-
terventricular septum and the left ventricular free wall. Rep-
resentative small specimens were obtained for histopath-
ologic examination from the right ventricle, left ventricle
and septal sections and the remaining specimens were scanned
on the camera face.
The tissue samples were fixed in 10% neutral buffered
formalin and routinely processed for light microscopy. Five
micron sections were cut and stained with hematoxylin-
phloxine-saffron. Adjacent portions of fresh tissue for im-
munohistologic study were placed in OCT compound (Lab-
Tek) in plastic BEEM capsules and sn"pfrozen in dry ice
and isopentane, then stored at - 70°C.
Rejection was graded semiquantitatively using an ad-
aptation of the method of Billingham (12). The following
scale was used: 0 = no rejection; I = mild mononuclear
cell infiltrate; 2 = moderate mononuclear infiltrate with rare
myocyte necrosis; and 3 = severe mononuclear infiltrate
plus sheets of myocyte necrosis. The degree of rejection
was graded from 0.5 to 3.0 without knowledge of the dog's
treatment protocol or the results of the radionuclide scans.
It should be noted that in patients receiving cyclosporine,
the presence of a mononuclear infiltrate alone (grade I) is
not considered rejection requiring treatment. Only the pres-
ence of myocyte necrosis or a persistent heavy lymphocytic
infiltrate, or both, is judged as treatable rejection (1,3).
Tissue samples were taken from the anterior and posterior
portions of right and left ventricular free walls and from the
interventricular septum; thus, a minimum of six sections
were examined from each heart. In addition, each free wall
sample was divided into three zones (epicardium, midpor-
tion and endocardium) and each zone was assessed sepa-
rately. The interventricular septum was also divided into
zones (right and left endocardium and midportion). A final
histologic rejection score was obtained by averaging the
individual scores for all the zones in the right ventricle,
septum and left ventricle for each heart.
Immunohistologic studies. These studies were also per-
formed to determine if the indium-III antimyosin was lo-
calized only to areas of myocyte necrosis. Tissues for im-
munoperoxidase study were maintained at - 70°C until the
time of staining. They then were removed from the BEEM
capsules without thawing and were mounted on cryostat
chucks with more OCT compound. Frozen sections, 5 /Lm
in thickness, were cut, placed on glass slides and fixed for
2 minutes in acetone. Subsequent staining included incu-
bation in 0.3% hydrogen peroxide in methanol to block
endogenous peroxidase activity, then incubation in 10%
normal goat serum in phosphate-buffered saline solution,
pH 7.2, followed by incubation with a 25 /Lg/ml solution
of peroxidase-conjugated goat anti-mouse IgG (F[ab'h spe-
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Table 2. Heterotopic to Native Heart Count Ratios* and Histopathologic Rejection Scores
Baseline Rejection Excised Pathologic Excised Heart Tissue
Scan Ratio Scan Ratio Heart Ratio Rejection Score Section Ratios
Acute
Dog 1 4.39 7.69 2.5 RV > LV
Dog 2 4.44 7.35 2.5 LV > RV
Chronic
Dog 3 1.79 1.68 0.25 LV > RV
Dog 4 1.08 2.32 2.85 1.06 LV > RV
Dog 5 1.40 5.70 6.90 2.75 RV > LV
Dog 6 2.39 1.89 1.82 0.58 LV > RV
*AII ratios compare average counts/pixel of the heterotopic with the native heart in each dog. LV = left ventricle; RV = right ventricle.
graphic evidence of rejection (Fig. I). Increased radioac-
tivity was diffusely present throughout both ventricles of
the heterotopic hearts. The heterotop ic to native heart count
ratios from these SPECT images were 4. 39 for Dog I and
Figure 2. Planar indium images of the six individual heart sections
from Dog 1 (A) and Dog 2 (B) . The heart sections are arranged
from left to right: left ventricle, septum, right ventricle. Native
heart sections are on the top of each group; heterotopic sections
on the bottom. All three heterotopic sections show high counts
compared with the native heart sections. There are focal regions
of increased uptake within individual sections in both dogs. In
Dog 2 (B) , the indium activity ratio is greater in the left than in
the right ventricle, whereas in Dog I (A) there is one focal area
of intensity in the right ventricle that makes the overall count ratio
greater for the right than for the left ventricle.
A
-
- -
B
4.44 for Dog 2 (Table 2). The heterotopic to native heart
count ratios for the excised hearts of Dogs I and 2 scanned
on the camera face were 7.69 and 7 .35, respectively. The
count ratios for the individual tissue sections of each heart
were highest for the right ventr icle in Dog I and for the left
ventricle in Dog 2. Figure 2 shows images of the cardiac
sections on the camera face and demonstrates that all the
indium activity is localized to the heterotopic heart , whereas
the native heart shows only background activity. In addition,
there are focal areas of more intense activity within some
regions of the left or right ventricles.
Histopathologic examination. Examination of the two
native hearts showed no pathologic changes. The allograft
in Dog I showed severe rejection (total score 2.5) in all
portions of the right ventricle , left ventricle and septum;
this was accompanied in the right ventricle by marked vas-
culitis. The rejection was histologically more severe in the
right than in the left ventricle. In Dog 2, the allograft also
showed moderate to severe rejection with an average score
of 2.5. Examples of the histopathologic features of moderate
and severe rejection are illustrated in Figure 3B and C. In
this dog, the score was higher for the left ventricle than for
the right ventricle or septum. There was no vasculitis evident
in this allograft that had been transplanted for only 4 days.
Immunoperoxidase studies. The studies using peroxi-
dase-conjugated goat anti-mouse IgG in these dogs (and also
in the chronic dog model) demonstrated that indium-Ill
antimyosin was localized to areas of cardiac myocyte ne-
crosis . Peroxidase staining showed a deposition of anti-
myosin antibody along the disrupted sarcolemmal surfaces
of necrotic myocytes. No antibody was demonstrated in
areas of interstitial edema in the absence of myocyte ne-
crosis, in vessels disrupted by vasculitis or in normal myo-
cardium.
Chronic Allograf t Rejection
There was no clearly visible uptake of indium-Ill an-
timyosin in planar or SPECT images of the native heart in
the four dogs with a long-term cardiac transplant. Faint,
diffuse uptake was apparent in the cardiac allograft of all
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Figure 3. Light microscopic sections of heterotopic cardiac al-
lografts. A, Mild rejection with interstitial lymphocytic cellular
infiltrate; B, moderate rejection with more extensive infiltrate and
focal myocyte necrosis; C, severe rejection with extensive necrosis
of myocytes and cellular infiltrate.
of these dogs that received long-term immunosuppression,
but intense indium-III activity was found only in those
with electrocardiographic evidence of rejection.
Dog 3. This dog was imaged and killed as a control
while receiving immunosuppressive therapy. The hetero-
topic to native heart count ratio obtained from the SPECT
images of the two hearts was 1.79 and the count ratio from
the images of the excised specimens was 1.68. Histologic
examination of the allograft showed negligible evidence of
rejection with a total score of 0.25. An ancillary finding in
the epicardial and larger intramyocardial vessels of the al-
lograft was the presence of extensive, accelerated athero-
sclerosis. There were also areas of old infarct in the right
ventricle, left ventricle and septum with myocyte dropout
and healing with fibrosis. The immunoperoxidase studies
did not show deposition of indium-III antimyosin in these
areas of old healed infarct.
Dogs 4, 5 and 6. These dogs were each studied twice
to investigatethe changes in scans that occur with rejection.
The heterotopicto native heart count ratios from the SPECT
images of Dog 4 were 1.08 at baseline and 2.32 16 days
after immunosuppression was withdrawn. The heterotopic
to native heart count ratio of the excised heart was 2.85.
Light microscopy revealed mild rejection (Fig. 3A) with a
total score of 1.06. In this heart, the left ventricle showed
more intense rejection than did the right ventricle.
Figure 4 shows the scans of Dog 5 which received a
transplant 9 months before study . The baseline study shows
faint. diffuse indium-III antimyosin uptake in the hetero-
topic but not in the native heart. When a repeat scan was
performed 27 days after immunosuppression was with-
drawn. the heterotopic heart displayed intense indium-III
uptake with a few focal areas of greater activity. The het-
erotopic to native heart count ratio from the SPECT images
of this dog's heart was 1.4 at baseline and increased to 5.7
on the second scan obtained at the time of clinical rejection.
The count ratioof the excised hearts was 6.9. In these hearts.
the count ratios obtained from the images of the tissue sec-
tions were highest in the right ventricle. The pathologic
examination showed extensive severe rejection in all sec-
Figure 4. Dog 5. A, Baseline left lateral planar indium image
showsfaintdiffuseuptakeof indiumin the regionof the heterotopic
heart. B, Left lateralplanarindiumimageduringallograftrejection
27 days after cessation of immunosuppression, showing more in-
tense uptake in the transplanted heart. C, SPECr images from the
baseline study. Left, A I cm thick midlinelong axis slice showing
diffuse mild indium-III uptake in the heterotopic heart. Note the
contrastenhancement producedby theSPECr reconstruction com-
paredwith the planarimage(A). The sameslice fromthe thallium-
20I scan on the right delineates the cardiac borders of both the
heterotopic and native hearts.
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tions with a total score of2.75. A mild vasculitis was present
in muscular vessels in the sections from the right ventricle,
whereas a more marked vasculitis was present in the left
ventricle and septum. In addition, there was acute ischemic
change manifested as a coagulative necrosis of myocardial
cells and necrosis of infiltrating cells without any poly-
morphonuclear cell reaction. The age of the infarct was
therefore estimated at 12 to 48 hours. The infarct appeared
to be due to the vasculitis of rejection, with subsequent
thrombosis and infarction.
Dog 6 had evidence of spontaneous rejection by electro-
cardiogram at the time of the baseline scintigraphic study;
this dog was continued on the same immunosuppressive
medications for 2 weeks longer and was then restudied.
Greater indium-Ill uptake was present in the heterotopic
heart on the baseline scan compared with the final scan.
The heterotopic to native heart count ratio from the baseline
SPECT image was 2.39, which decreased to 1.89 on the
second scan 2 weeks later. In this dog, the heterotopic to
native heart count ratio for the excised hearts was 1.82 and
the ratio from the tissue sections was highest for the left
ventricle. Histopathologically, there was very mild rejection
predominantly in the left ventricle with a total score of 0.58.
There was moderate allograft atherosclerosis and in the left
ventricle there were numerous foci of healing in which myo-
cardial tissue had been removed and replaced by mononu-
clear inflammatory cells, edema, granulation tissue and fi-
brosis. There was no evidence of active necrosis of myocardial
fibers, which suggests that the focal healing may have rep-
resented resolving rejection or the repair that follows isch-
emic infarction. The histologic appearance suggested that
the damage may have occurred 2 to 3 weeks before the
dog's death, coinciding with the timing of the first study.
Comparisons. The heterotopic to native heart count ra-
tios obtained from the in vivo SPECT images of both hearts
in each dog before death correlated positively with the het-
erotopic to native heart ratios obtained when sections from
the excised hearts were scanned on the face of the scintil-
lation camera (r = 0.93) (Fig. 5A). When the total rejection
scores obtained from the pathologic examination were com-
pared with the SPECT ratios, an excellent correlation (r =
0.97) was demonstrated (Fig. 58).
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Discussion
Figure 5. A, Comparison of heterotopic to native heart (H/N)
count ratios in SPECT images (ordinate) and in vitro scans of
tissue sections (abscissa). B, Comparison of H/N count ratios in
SPECT images (ordinate) and histopathologic rejection scores
(abscissa).
Cardiac transplantation has become a more common ther-
apeutic approach in recent years. Improved survival is judged
to be secondary to the use of cyclosporine and prednisone
for immunosuppression instead of the previous regimen of
azathioprine and prednisone. However, the precise detection
of allograft rejection remains a major problem in these pa-
tients. With azathioprine treattnent, rejection was almost
universally accompanied by myocardial edema and lym-
phocytic infiltrate, and therefore a drop in electrocardio-
graphic voltage. In contradistinction, rejection in cyclos-
porine-treated patients is usually clinically silent, and current
diagnostic techniques depend on evidence of myocyte ne-
crosis on endomyocardial biopsy, which is performed rou-
tinely to detect rejection in its early phases (1,3).
Although utilization of this invasive surveillance tech-
nique in the clinical setting is undesirable because of in-
convenience and some morbidity, other noninvasive mea-
sures (such as M-mode or two-dimensional echocardiography
or high frequency averaging of the electrocardiogram) are
indirect measures of the effects of cardiac rejection on heart
function, whereas antimyosin uptake is a direct result of the
myocyte necrosis on a cellular level (3-5). Previous radio-
nuclide studies (14-16) have been performed using lym-
phocytes labeled with either indium or technetium in non-
immunosuppressed or azathioprine-treated rats. These studies
showed increased cardiac radioactivity associated with car-
diac rejection. However, because mild lymphocyte infiltra-
tion is a relatively nonspecific pathologic finding in cardiac
transplant patients receiving cyclosporine, and more marked
lymphocyte infiltration without myocyte necrosis unless per-
sistent, is usually not regarded as an indication for additional
therapy for rejection (1,3), these radionuclide techniques
have not been widely used.
Detection of rejection. Our data indicate that SPECT
imaging of indium-III antimyosin is capable of detecting
myocyte necrosis due to cardiac allograft rejection. There
was no significant uptake of the radiolabeled antibody to
cardiac myosin in the normal dogs scanned before surgery
or in the native hearts of the dogs with acute or chronic
rejection of the cardiac allografts. In contrast, there was
intense uptake of indium-Ill antimyosin in the cardiac al-
lografts that exhibited electrocardiographic or histologic evi-
dence of rejection. When the myocardial tissues were counted
postmortem, there was excellent correlation between the
ratios of counts in the heterotopic and normal hearts and
those obtained from the tomographic reconstructions of the
in vivo SPECT imaging. The SPECT count ratios also cor-
related highly with the histopathologic scoring of the mul-
tiple tissue samples used to grade the severity of the rejection
process. These results indicate that the quantitative data
obtained from the noninvasive SPECT images of indium-
III antimyosin uptake were indicative of the severity of
myocyte necrosis due to acute or chronic rejection of the
heterotopic hearts. This conclusion was reinforced by the
histopathologic studies with immunofluorescence and per-
oxidase. These studies revealed the presence of the anti-
cardiac myosin Fab only in areas of myocyte necrosis. There
was no apparent localization of the Fab in normal myocar-
dium, in areas of interstitial edema or in the blood vessels
disrupted by vasculitis.
To investigate whether SPEeT imaging with indium-Ill
antimyosin could detect serial changes over time, three dogs
were each studied twice, before and after the development
of rejection. Two of these dogs (Dogs 4 and 5) with no
clinical evidence of rejection before their first scan devel-
oped electrocardiographic signs of rejection after their im-
munosuppression was discontinued. The ratios of the in-
dium-Ill antimyosin uptake in the heterotopic to native
hearts of these dogs increased proportionately to the degree
of histopathologic rejection found at death. The third dog
(Dog 6) had evidence of spontaneous rejection by electro-
cardiogram at the time of the baseline study. Immuno-
suppression was continued at the same dosage and when
SPECT scanning of this dog was repeated there was de-
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creased indium-III antimyosin uptake compared with that
at the baseline study, accompanied by pathologic evidence
of resolving allograft rejection. These data imply that a
decreasing heterotopic to native heart ratio on scanning may
be a sign of resolving damage. Serial imaging with indium-
III antimyosin may be useful in following the responses
of cardiac allografts to treatment for rejection.
Pattern of rejection. In the present study, evidence of
allograft rejection by in vitro scanning (indium-III anti-
myosin uptake) and histopathologic examination was found
to be greater in the left than in the right ventricle in four of
the six dogs. Other workers have also found an asymmetric
pattern of rejection. Haverich et al. (17) studied primates
after orthotopic cardiac transplantation. Although they found
histologic evidence of rejection to be more severe in the
right than in the left ventricle, there was a lesser degree of
rejection in the right ventricularendocardiumcompared with
its midlayer, and less still in the right septal midlayer com-
pared with the right ventricular free wall. The discrepancy
between our results and those of these investigators may be
due to differences in coronary circulation between primates
and dogs, our small sample size or the use of a heterotopic
model in our study. However, in both studies an asymmetric
pattern of rejection was observed and in our study it was
detected by antimyosin antibody. In current clinical man-
agement of patients with a cardiac transplant, it is assumed
that the degree of rejection found on endomyocardial biopsy
from the right ventricular septum reflects the degree of re-
jection throughout the entire heart. Biopsies, however, which
sample only very small areas of the endocardial surface,
may easily miss patches of rejection present elsewhere in
the heart and may only detect rejection when it is sufficiently
advanced to involve the entire right ventricle. In our in vivo
studies with SPECT, it was difficult to distinguish the right
and left ventricles because of the anatomicdistortion created
by placing the cardiac allograft in each host dog's chest.
However, in orthotopic transplants it should be possible
using SPECT to identify the cardiac chambers and to detect
cardiac rejection scintigraphically when it occurs in areas
other than the right ventricular septum.
Low grade cardiac rejection and accelerated coronary
atherosclerosis. Low grade cardiac allograft rejection that
is not detected by electrocardiogram or by routine endo-
myocardial biopsy may be present in animals or in patients
maintained on long-term immunosuppressive therapy. Long-
term follow-upof cardiac transplant patientson cyclosporine
immunosuppression has shown evidence of increased intra-
myocardial fibrosis and accelerated coronary atherosclerosis
in many. Although the pathogenesis of these changes is
uncertain, they are thought to be a consequence of recurrent
immunologic damage to the endothelium of the coronary
vessels that occurs during undetected low level rejection
(18). In our study, a faint uptake of indium-III antimyosin
was observed in the chronically transplanted hearts of Dogs
3, 4 and 5 in the first study while they were receiving
immunosuppressive therapy and had no electrocardio-
graphic evidence of rejection. Although histologic confir-
mation of rejection was not obtained until after the second
study in Dogs 4 and 5, when drugs were withdrawn, the
finding of low grade anticardiac myosin uptake in the im-
munosuppresseddogs suggests these animals may have had
a very low level of rejection. The extensive coronary vas-
cular disease present in some chronically immunosuppressed
dogs in our study is compatible with this speculation. Graft
atherosclerosiswas apparent in two of our chronically trans-
planted dogs and by itself did not seem to increase indium-
III antimyosin uptake. Old healed infarction as seen in Dog
3 also did not increase indium-III uptake. We can only
speculate that antimyosinantibody imaging may also be able
to detect small silent myocardial infarcts that can occur
secondary to the premature atherosclerosis.
Limitations of imaging technique. There are several
disadvantages of indium-III antimyosin imaging in its cur-
rent stateof development: I) Becausethe tracer clears slowly
from the blood pool, optimal images of the myocardium
cannot currently be obtained until 24 to 48 hours after in-
travenous injection. 2) The long half-life and high energy
of indium-III increases the radiation burden to the main
target organ, the kidney, which limits the dosage per in-
jection and the number of possible injections per year. Use
of other radionuclides such as iodine-123 to label the an-
timyosin may reduce the radiation burden to the patient from
serial imaging. 3) Although Fab fragments are less likely
to cause allergic reactions than are whole antibodies (be-
cause of more rapid excretion by the kidneys), there is a
small but significantpossibility of allergic or hypersensitive
reactions associated with multiple injections of foreign pro-
tein. Pertinent to this possibility, however, are data from a
recent multicenter trial (19) in which a murine OKT3 mono-
clonal antibody was administered repeatedly to 197 patients
with a renal transplant for 14 days as therapy for acute
rejection with no episodes of anaphylaxis, hypersensitivity
or serum sickness. 4) Because antimyosin antibodies are
taken up by necrotic myocytes, indium-Ill antimyosin im-
aging would not distinguish between rejection and the co-
agulative necrosis that can be seen on the first posttransplant
biopsy of patients receiving high dose vasopressors or those
with distantly obtained hearts. For this reason, we envision
this technique to be more useful in the later follow-up pe-
riod.
Conclusions. Our data show that SPECT and planar
imaging of indium-Ill antimyosin can detect, localize and
quantifycardiac allograft rejection indogs with a heterotopic
cardiac transplant. They suggest that in patients with an
orthotopic cardiac transplant, noninvasive detection and
quantitation of rejection from planar and SPECT indium
antimyosin scans may be possible. Obviously, to obtain
quantitative data concerning uptake of indium activity in a
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heart in the orthotopic position, corrections for attenuation
and background activity would be necessary. A prospective
study comparing SPECT indium-III antimyosin imaging
with results of endomyocardial biopsy for the detection of
cardiac transplantation rejection is currently under way in
our institution. If successful, this approach will have the
advantage of being noninvasive and could potentially de-
crease the number of endomyocardial biopsies performed
on the patients after cardiac transplantation.
We are grateful to Leonard L. Norbert for expert word processing.
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